Buscar
-
Targeting of under-75 years for the optimization of medication reconciliation with an approach based on medication risks: An observational study
(Thérapie, 2021-06-18)Article de revue -
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.
(Frontiers in Pharmacology. vol. 14, pp. 1129244, 2023-05-15)Article de revueLibre acceso -
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
(Frontiers in Endocrinology. vol. 14, pp. 1254221, 2023-09-25)Article de revueLibre acceso -
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use
(Frontiers in Psychiatry. vol. 13, 2022-06-30)Article de revueLibre acceso -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre acceso -
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
(Therapies. vol. 78, n° 1, pp. 115-129, 2022-11-25)Article de revue -
ADL-dependent older adults were identified in medico-administrative databases
(Journal of Clinical Epidemiology, 2021-06-21)Article de revue -
Antiherpetic drugs: a potential way to prevent Alzheimer's disease?
(Alzheimer's Research and Therapy. vol. 14, n° 1, pp. 3, 2022-01-07)Article de revueLibre acceso -
Dilemma, an innovative public health scientific animation for the youth, France, 2022
Communication dans un congrès